Strides Shasun Q3FY17 Results

Bhagyashree Vivarekar / 03 Feb 2017

Strides Shasun Q3FY17 Results

The company's PAT was Rs 196.3 crore, which represents a sequential QoQ increase of 129.59 per cent and a YoY increase of 236.71 per cent.

Strides Shasun Ltd. reported its consolidated results for the quarter ended December 31, 2016  today.

The company’s sales for Q3FY17 were Rs 933.9 crore, which represents a 2.05 per cent sequential decline and 7.72 per cent YoY increase.

Its operating profit (EBIT) for the quarter was Rs 148.4 crore and its EBIT margin was 15.89 per cent.

The company's PAT was Rs 196.3 crore, which represents a sequential QoQ increase of 129.59 per cent and a YoY increase of 236.71 per cent.

Strides Shasun Ltd is an Indian pharmaceutical company that focuses on the development and manufacture of IP-led niche products, particularly sterile injectables. The company has business interests in specialty pharmaceuticals, pharma generics and branded generics and also manufactures soft gelatin capsules.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.